S&P DJI Announces March 2025 Quarterly Rebalance
Filed with ASX · · 8 pages · English
Botanix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Botanix Pharmaceuticals
- December 2024 Quarterly Activities Report and Appendix 4C
- First Sofdra Prescriptions as Commercialisation Ramps Up
- Botanix Pharmaceuticals: Releases Quarterly Reports
- September 2024 Quarterly Activities Report and Appendix 4C
- Botanix Appendix 4E & Announcement of Commercial Day Webinar
Later from Botanix Pharmaceuticals
- Botanix Conference Commercial Update
- Botanix $40 Million Capital Raising for Sofdra Rollout
- March 2025 Quarterly Activities Report and Appendix 4C
- Pause in trading
- Botanix Responds to US Pharmaceutical Pricing Announcement
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals